| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052265560 |
| P356 | DOI | 10.1038/SJ.BMT.1700674 |
| P698 | PubMed publication ID | 9051251 |
| P2093 | author name string | Kato S | |
| Morimoto T | |||
| Shimizu T | |||
| Hinohara T | |||
| Shimamura K | |||
| Hattori K | |||
| Tang X | |||
| Yabe H | |||
| Takakura I | |||
| Yabe M | |||
| P433 | issue | 4 | |
| P921 | main subject | lung disease | Q3392853 |
| dyskeratosis congenita | Q3709312 | ||
| P304 | page(s) | 389-392 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation | |
| P478 | volume | 19 |
| Q36782745 | A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation |
| Q36411101 | A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition |
| Q63384262 | A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita |
| Q34431411 | Bone marrow failure and the telomeropathies |
| Q34935851 | Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita |
| Q58417594 | Diagnostic utility of telomere length measurement in a hospital setting |
| Q49790251 | Diagnostic utility of telomere length testing in a hospital-based setting |
| Q53330217 | Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. |
| Q58388056 | Dyskeratosis congenita |
| Q35558515 | Dyskeratosis congenita: its link to telomerase and aplastic anaemia |
| Q90485064 | Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita |
| Q81311486 | Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen |
| Q45800411 | Fludarabine, low-dose cyclophosphamide and rabbit antithymocyte globulin allowed stable engraftment after allogeneic peripheral blood stem cell transplantation for poly-transfused dyskeratosis congenita patient: case report |
| Q37285981 | Genetic and environmental factors influencing human diseases with telomere dysfunction. |
| Q24626239 | Genetic interstitial lung disease |
| Q24536887 | Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita |
| Q81073729 | Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita: report of a case |
| Q42213782 | Liver Transplantation After Bone Marrow Transplantation for End Stage Liver Disease with Severe Hepatopulmonary Syndrome in Dyskeratosis Congenita: A Literature First. |
| Q35128245 | Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita |
| Q33933652 | Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review |
| Q33346928 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita |
| Q33976506 | Pathogenesis of idiopathic pulmonary fibrosis |
| Q46177519 | Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. |
| Q34255048 | Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita. |
| Q57803557 | Short telomere syndromes cause a primary T cell immunodeficiency |
| Q34563497 | Short telomeres, even in the presence of telomerase, limit tissue renewal capacity |
| Q35030917 | Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase |
| Q33638357 | Syndromes of telomere shortening |
| Q24655738 | TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita |
| Q38101746 | Telomeres in lung disease |
| Q37300909 | The genetics and clinical manifestations of telomere biology disorders |
| Q36516357 | The role of telomere biology in bone marrow failure and other disorders |
| Q35428973 | Transplantation for congenital bone marrow failure syndromes |
| Q47783078 | Usual interstitial pneumonia complicating dyskeratosis congenita |
Search more.